Pfizer Inc. (NYSE: PFE) and Moderna Inc. (NASDAQ: MRNA) have made significant progress in their efforts to develop a vaccine against the
Inovio Pharmaceuticals Inc.
-(INO)
XNAS:INO
Inovio (INO) aims to produce 100 million doses of COVID-19 vaccine in 2021
Shares of INOVIO (NASDAQ: INO) were down over 23% on Tuesday, a day after the company reported second quarter 2020 earnings results
Rallies you may have missed: 6 stocks that soared in 2020
This year, we saw long red candles replacing clowns as the ultimate symbol of horror. It has given sleepless nights to not
INOVIO Pharmaceuticals expects results from initial trials for COVID-19 vaccine next month
INOVIO Pharmaceuticals (NASDAQ: INO), which is among the frontrunners in developing a vaccine for the coronavirus disease, said during its post-earnings conference
Inovio Pharmaceuticals Inc (NASDAQ: INO) Q1 2020 Earnings Call Transcript
Inovio Pharmaceuticals Inc (INO) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Ben Matone -- Investor Relations J. Joseph Kim, Ph.D. -- President, Chief